RecruitingNCT07422987
GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women
Sponsor
University of Kansas Medical Center
Enrollment
50 participants
Start Date
Feb 12, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
This study is designed with the interest to learn on the effects of estrogen levels and how it affects body compositions and muscle function in midlife women who are taking a GLP-1RA for weight loss.
Eligibility
Sex: FEMALEMin Age: 35 YearsMax Age: 60 Years
Inclusion Criteria6
- Females
- Age 35-60 year
- BMI≥30 or BMI≥27 and at least one cardiometabolic risk factor (dyslipidemia, hypertension, obstructive sleep apnea, metabolic syndrome, fatty liver, PCOS)
- Newly prescribed a GLP-1RA medication
- English speaking
- Body weight stable for the past 6 months
Exclusion Criteria9
- Pregnant women
- Under age 35 or over age 60
- Born male
- Cannot consent for themselves
- Cannot read and speak in English
- Type 2 diabetes
- Recently discontinued a GLP-1RA medication (less than 6-months since discontinuing)
- Contraindications for taking a GLP-1 RA medication (personal or family history of medullary thyroid carcinoma, personal or family history of multiple endocrine neoplasia type 2, personal history of pancreatitis, pregnancy, hypersensitivity to the drug or any component of the drug, active suicidal ideation)
- Currently taking aromatase inhibitors or selective estrogen receptor modulators (SERMs)
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07422987
Related Trials
The Effect of Urolithin A (Mitopure®) Supplementation on Muscle Strength in Healthy Middle-Aged Adults
NCT072317831 location
Dose-Response Impact of Geranylgeraniol (GG) Supplementation on Muscle Health
NCT075029241 location
Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes
NCT067356511 location
EMS Combined With Resistance Training in Weight Lifters
NCT074846461 location
Longitudinal Body Composition Assessment in Breast Cancer Patients
NCT074728031 location